10x Genomics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
10x Genomics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • 10x Genomics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $443M, a 21.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $443M +$78.8M +21.6% Dec 31, 2023 10-K 2024-02-15
Q4 2022 $364M +$51.1M +16.3% Dec 31, 2022 10-K 2024-02-15
Q4 2021 $313M +$126M +67.6% Dec 31, 2021 10-K 2023-02-16
Q4 2020 $187M +$120M +181% Dec 31, 2020 10-K 2022-02-18
Q4 2019 $66.5M +$10.8M +19.4% Dec 31, 2019 10-K 2021-02-26
Q4 2018 $55.7M Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.